Nukhet Aykin-Burns
Concepts (346)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mitochondria | 19 | 2023 | 505 | 2.230 |
Why?
| Oxidative Stress | 23 | 2023 | 953 | 1.720 |
Why?
| Osteoclasts | 7 | 2022 | 472 | 1.480 |
Why?
| Sirtuin 3 | 7 | 2023 | 17 | 1.400 |
Why?
| Antioxidants | 6 | 2023 | 297 | 0.910 |
Why?
| Polychlorinated Biphenyls | 2 | 2013 | 26 | 0.830 |
Why?
| Cosmic Radiation | 1 | 2021 | 38 | 0.800 |
Why?
| Reactive Oxygen Species | 9 | 2016 | 494 | 0.800 |
Why?
| Tocotrienols | 2 | 2019 | 42 | 0.790 |
Why?
| Cell Compartmentation | 1 | 2020 | 17 | 0.770 |
Why?
| Green Fluorescent Proteins | 1 | 2020 | 110 | 0.740 |
Why?
| Osteogenesis | 3 | 2021 | 381 | 0.740 |
Why?
| Radiation-Protective Agents | 2 | 2019 | 117 | 0.730 |
Why?
| Bone Resorption | 4 | 2022 | 326 | 0.670 |
Why?
| Vitamin E | 1 | 2019 | 108 | 0.620 |
Why?
| Superoxide Dismutase | 9 | 2023 | 125 | 0.620 |
Why?
| Animals | 35 | 2023 | 14435 | 0.600 |
Why?
| Mice | 22 | 2023 | 6436 | 0.540 |
Why?
| Linear Energy Transfer | 2 | 2013 | 17 | 0.510 |
Why?
| Keratinocytes | 2 | 2013 | 96 | 0.490 |
Why?
| Neoplasms | 3 | 2023 | 1309 | 0.490 |
Why?
| Cystine | 2 | 2020 | 15 | 0.470 |
Why?
| Radiation Tolerance | 3 | 2013 | 89 | 0.470 |
Why?
| Aging | 4 | 2021 | 786 | 0.470 |
Why?
| Cell Proliferation | 5 | 2014 | 1099 | 0.450 |
Why?
| Prostate | 1 | 2013 | 112 | 0.450 |
Why?
| Air Pollutants | 1 | 2013 | 70 | 0.450 |
Why?
| Environmental Pollutants | 2 | 2013 | 102 | 0.440 |
Why?
| Radiation, Ionizing | 5 | 2022 | 121 | 0.430 |
Why?
| Acetylcysteine | 5 | 2016 | 118 | 0.420 |
Why?
| Deoxyglucose | 5 | 2010 | 27 | 0.410 |
Why?
| Environmental Exposure | 1 | 2013 | 206 | 0.410 |
Why?
| Epithelial Cells | 1 | 2013 | 256 | 0.410 |
Why?
| Iron | 3 | 2022 | 158 | 0.370 |
Why?
| Oxygen | 2 | 2011 | 358 | 0.360 |
Why?
| Cell Movement | 1 | 2011 | 276 | 0.360 |
Why?
| PC12 Cells | 2 | 2006 | 29 | 0.340 |
Why?
| Hydrogen Peroxide | 3 | 2020 | 140 | 0.340 |
Why?
| Fibroblasts | 6 | 2016 | 386 | 0.330 |
Why?
| Cell Line, Tumor | 9 | 2020 | 1542 | 0.330 |
Why?
| Glutathione | 11 | 2016 | 330 | 0.330 |
Why?
| Membrane Proteins | 1 | 2010 | 391 | 0.320 |
Why?
| Antineoplastic Agents | 4 | 2023 | 1295 | 0.310 |
Why?
| Organoselenium Compounds | 1 | 2006 | 2 | 0.280 |
Why?
| Apoptosis | 7 | 2020 | 1306 | 0.280 |
Why?
| Organometallic Compounds | 1 | 2006 | 46 | 0.270 |
Why?
| Lead | 1 | 2005 | 32 | 0.270 |
Why?
| Superoxides | 4 | 2013 | 61 | 0.260 |
Why?
| Cricetinae | 5 | 2021 | 211 | 0.260 |
Why?
| Male | 17 | 2023 | 27350 | 0.260 |
Why?
| Cell Survival | 7 | 2015 | 661 | 0.260 |
Why?
| Mutation | 1 | 2010 | 1499 | 0.240 |
Why?
| Dose-Response Relationship, Drug | 5 | 2015 | 1478 | 0.230 |
Why?
| Fertility Preservation | 1 | 2023 | 7 | 0.230 |
Why?
| Animals, Wild | 1 | 2023 | 11 | 0.230 |
Why?
| Glutathione Disulfide | 6 | 2011 | 45 | 0.220 |
Why?
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2020 | 62 | 0.220 |
Why?
| Adenosine Triphosphate | 3 | 2020 | 253 | 0.220 |
Why?
| Receptors, Transferrin | 1 | 2022 | 17 | 0.220 |
Why?
| Mice, Knockout | 6 | 2022 | 941 | 0.220 |
Why?
| Oxidative Phosphorylation | 2 | 2020 | 60 | 0.210 |
Why?
| Cells, Cultured | 5 | 2020 | 1755 | 0.210 |
Why?
| Estrogens | 2 | 2021 | 246 | 0.210 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 208 | 0.210 |
Why?
| Oxidation-Reduction | 3 | 2020 | 384 | 0.210 |
Why?
| Rats | 8 | 2021 | 3435 | 0.210 |
Why?
| Carrier Proteins | 2 | 2014 | 360 | 0.210 |
Why?
| Protein C | 1 | 2021 | 24 | 0.200 |
Why?
| Hippocampus | 1 | 2023 | 240 | 0.200 |
Why?
| Mice, Inbred BALB C | 1 | 2021 | 368 | 0.190 |
Why?
| Humans | 25 | 2023 | 54132 | 0.190 |
Why?
| Monocyte-Macrophage Precursor Cells | 1 | 2020 | 8 | 0.190 |
Why?
| Transduction, Genetic | 1 | 2020 | 49 | 0.190 |
Why?
| Subcellular Fractions | 1 | 2020 | 44 | 0.190 |
Why?
| Biosensing Techniques | 1 | 2020 | 28 | 0.190 |
Why?
| Catalase | 6 | 2016 | 74 | 0.190 |
Why?
| Cricetulus | 3 | 2010 | 103 | 0.190 |
Why?
| Cysteine | 1 | 2020 | 67 | 0.190 |
Why?
| Cytosol | 1 | 2020 | 104 | 0.190 |
Why?
| Cell Line | 5 | 2015 | 1166 | 0.190 |
Why?
| Cognition | 1 | 2023 | 350 | 0.180 |
Why?
| Intestine, Small | 1 | 2021 | 139 | 0.180 |
Why?
| Neoplasms, Experimental | 1 | 2020 | 115 | 0.180 |
Why?
| Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 74 | 0.180 |
Why?
| Female | 15 | 2023 | 28437 | 0.180 |
Why?
| Cell Transformation, Neoplastic | 2 | 2011 | 200 | 0.180 |
Why?
| Microscopy, Fluorescence | 1 | 2020 | 196 | 0.180 |
Why?
| Osteoporosis | 1 | 2021 | 165 | 0.180 |
Why?
| Image Processing, Computer-Assisted | 1 | 2020 | 256 | 0.170 |
Why?
| Myeloid Cells | 1 | 2018 | 37 | 0.160 |
Why?
| Cation Transport Proteins | 1 | 2018 | 28 | 0.160 |
Why?
| Buthionine Sulfoximine | 4 | 2016 | 17 | 0.160 |
Why?
| Time Factors | 6 | 2016 | 3223 | 0.160 |
Why?
| Mice, Inbred C57BL | 6 | 2022 | 2021 | 0.150 |
Why?
| Tumor Suppressor Protein p53 | 2 | 2011 | 251 | 0.150 |
Why?
| Skin | 1 | 2021 | 469 | 0.150 |
Why?
| Breast Neoplasms | 4 | 2014 | 1248 | 0.150 |
Why?
| MicroRNAs | 1 | 2021 | 387 | 0.150 |
Why?
| Models, Biological | 5 | 2014 | 824 | 0.150 |
Why?
| Peroxynitrous Acid | 2 | 2014 | 51 | 0.150 |
Why?
| Disease Models, Animal | 1 | 2023 | 1645 | 0.150 |
Why?
| Genetic Therapy | 2 | 2007 | 121 | 0.150 |
Why?
| Gene Deletion | 1 | 2018 | 296 | 0.150 |
Why?
| Heart | 2 | 2021 | 364 | 0.150 |
Why?
| bcl-2-Associated X Protein | 2 | 2014 | 74 | 0.140 |
Why?
| Radiation Injuries, Experimental | 2 | 2015 | 124 | 0.140 |
Why?
| CCAAT-Enhancer-Binding Protein-delta | 1 | 2016 | 25 | 0.140 |
Why?
| Epigenesis, Genetic | 2 | 2020 | 399 | 0.140 |
Why?
| DNA Breaks, Double-Stranded | 1 | 2016 | 78 | 0.140 |
Why?
| RNA, Messenger | 3 | 2015 | 1222 | 0.140 |
Why?
| Thrombomodulin | 1 | 2016 | 47 | 0.140 |
Why?
| Whole-Body Irradiation | 2 | 2015 | 160 | 0.140 |
Why?
| Myoblasts | 1 | 2015 | 20 | 0.140 |
Why?
| Malondialdehyde | 2 | 2006 | 63 | 0.140 |
Why?
| Guanidines | 1 | 2015 | 35 | 0.140 |
Why?
| Peptides | 2 | 2014 | 278 | 0.140 |
Why?
| Aniline Compounds | 1 | 2015 | 47 | 0.130 |
Why?
| Particulate Matter | 1 | 2015 | 55 | 0.130 |
Why?
| DNA Damage | 3 | 2015 | 358 | 0.130 |
Why?
| Signal Transduction | 5 | 2020 | 1754 | 0.130 |
Why?
| Mitochondria, Heart | 1 | 2015 | 42 | 0.130 |
Why?
| Intestines | 1 | 2016 | 206 | 0.130 |
Why?
| Recombinant Proteins | 1 | 2016 | 574 | 0.130 |
Why?
| Sulfonamides | 1 | 2015 | 147 | 0.130 |
Why?
| Enzyme Inhibitors | 2 | 2015 | 456 | 0.120 |
Why?
| Analgesics, Non-Narcotic | 1 | 2015 | 140 | 0.120 |
Why?
| beta Catenin | 1 | 2014 | 102 | 0.120 |
Why?
| Wnt Signaling Pathway | 1 | 2014 | 94 | 0.120 |
Why?
| Blotting, Western | 6 | 2015 | 685 | 0.120 |
Why?
| Hepatocytes | 1 | 2015 | 216 | 0.120 |
Why?
| Hematopoietic Stem Cells | 1 | 2015 | 215 | 0.120 |
Why?
| Selenoprotein P | 1 | 2013 | 1 | 0.120 |
Why?
| Hydroxylation | 1 | 2013 | 61 | 0.120 |
Why?
| Heavy Ions | 1 | 2013 | 17 | 0.120 |
Why?
| Cytoprotection | 1 | 2013 | 48 | 0.120 |
Why?
| Biotransformation | 1 | 2013 | 101 | 0.120 |
Why?
| Chromosome Aberrations | 1 | 2015 | 315 | 0.120 |
Why?
| Benzoquinones | 1 | 2013 | 33 | 0.120 |
Why?
| Gene Expression Regulation | 4 | 2021 | 1075 | 0.120 |
Why?
| Thymus Neoplasms | 1 | 2013 | 17 | 0.120 |
Why?
| Cell Respiration | 3 | 2022 | 56 | 0.120 |
Why?
| Neoplasms, Radiation-Induced | 1 | 2013 | 42 | 0.120 |
Why?
| Metabolome | 1 | 2014 | 109 | 0.110 |
Why?
| Genomic Instability | 2 | 2011 | 95 | 0.110 |
Why?
| Lymphoma | 1 | 2013 | 62 | 0.110 |
Why?
| DNA | 1 | 2016 | 582 | 0.110 |
Why?
| Macrophages | 1 | 2015 | 401 | 0.110 |
Why?
| Acetaminophen | 1 | 2015 | 349 | 0.110 |
Why?
| Rotenone | 2 | 2009 | 20 | 0.110 |
Why?
| Antimetabolites | 2 | 2010 | 12 | 0.100 |
Why?
| Liver Cirrhosis | 1 | 2014 | 216 | 0.100 |
Why?
| Succinate Dehydrogenase | 1 | 2011 | 28 | 0.100 |
Why?
| Sex Characteristics | 1 | 2013 | 217 | 0.100 |
Why?
| Protein Subunits | 1 | 2011 | 86 | 0.100 |
Why?
| Dyskeratosis Congenita | 1 | 2011 | 3 | 0.100 |
Why?
| Immunoblotting | 3 | 2021 | 134 | 0.100 |
Why?
| DNA Methylation | 1 | 2015 | 575 | 0.100 |
Why?
| Telomerase | 1 | 2011 | 30 | 0.100 |
Why?
| Myocardium | 1 | 2014 | 445 | 0.100 |
Why?
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2011 | 96 | 0.100 |
Why?
| Lipid Peroxidation | 2 | 2014 | 132 | 0.090 |
Why?
| Gene Expression | 5 | 2013 | 667 | 0.090 |
Why?
| Chromatography, High Pressure Liquid | 2 | 2015 | 376 | 0.090 |
Why?
| Electron Transport Complex II | 1 | 2009 | 12 | 0.090 |
Why?
| CHO Cells | 2 | 2009 | 125 | 0.090 |
Why?
| Glutathione Peroxidase | 2 | 2007 | 28 | 0.090 |
Why?
| Genes, Tumor Suppressor | 1 | 2010 | 85 | 0.090 |
Why?
| Wound Healing | 1 | 2011 | 231 | 0.090 |
Why?
| Zidovudine | 1 | 2008 | 6 | 0.090 |
Why?
| Werner Syndrome | 1 | 2008 | 14 | 0.090 |
Why?
| Membrane Potential, Mitochondrial | 3 | 2015 | 53 | 0.090 |
Why?
| Adult | 3 | 2021 | 14196 | 0.090 |
Why?
| Exodeoxyribonucleases | 1 | 2008 | 19 | 0.090 |
Why?
| Aged, 80 and over | 2 | 2021 | 3442 | 0.090 |
Why?
| RecQ Helicases | 1 | 2008 | 19 | 0.080 |
Why?
| Sirtuins | 1 | 2008 | 12 | 0.080 |
Why?
| Stress, Physiological | 1 | 2010 | 194 | 0.080 |
Why?
| Cell Differentiation | 2 | 2022 | 717 | 0.080 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2008 | 19 | 0.080 |
Why?
| Kidney | 1 | 2014 | 828 | 0.080 |
Why?
| Polyethylene Glycols | 3 | 2016 | 105 | 0.080 |
Why?
| Carmustine | 1 | 2007 | 13 | 0.080 |
Why?
| Tobacco Smoke Pollution | 1 | 2008 | 56 | 0.080 |
Why?
| Glucose | 2 | 2007 | 353 | 0.080 |
Why?
| Adenoviridae | 1 | 2007 | 60 | 0.080 |
Why?
| Forkhead Transcription Factors | 1 | 2008 | 118 | 0.080 |
Why?
| Mitochondrial Proteins | 1 | 2008 | 121 | 0.080 |
Why?
| Liver | 1 | 2014 | 1246 | 0.080 |
Why?
| Antineoplastic Agents, Alkylating | 1 | 2007 | 74 | 0.080 |
Why?
| Colonic Neoplasms | 1 | 2009 | 165 | 0.080 |
Why?
| Antiviral Agents | 2 | 2021 | 189 | 0.080 |
Why?
| Immunohistochemistry | 3 | 2021 | 1097 | 0.080 |
Why?
| Radiation-Sensitizing Agents | 1 | 2007 | 55 | 0.080 |
Why?
| Methionine | 1 | 2008 | 147 | 0.070 |
Why?
| Myocytes, Cardiac | 1 | 2008 | 136 | 0.070 |
Why?
| Glutamate-Cysteine Ligase | 1 | 2006 | 22 | 0.070 |
Why?
| Neurites | 1 | 2006 | 17 | 0.070 |
Why?
| Cisplatin | 1 | 2008 | 354 | 0.070 |
Why?
| Protein Kinase C | 1 | 2006 | 69 | 0.070 |
Why?
| Caspase 3 | 1 | 2006 | 136 | 0.070 |
Why?
| Trypan Blue | 1 | 2005 | 10 | 0.070 |
Why?
| Heart Diseases | 1 | 2008 | 238 | 0.070 |
Why?
| Caspases | 1 | 2006 | 147 | 0.070 |
Why?
| Drug Combinations | 1 | 2005 | 129 | 0.070 |
Why?
| Head and Neck Neoplasms | 1 | 2008 | 328 | 0.060 |
Why?
| Gene Knockdown Techniques | 2 | 2015 | 127 | 0.060 |
Why?
| Pancreatic Neoplasms | 1 | 2007 | 235 | 0.060 |
Why?
| Dose-Response Relationship, Radiation | 2 | 2016 | 215 | 0.060 |
Why?
| Transfection | 3 | 2011 | 410 | 0.060 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2015 | 157 | 0.060 |
Why?
| Prostatic Neoplasms | 1 | 2007 | 411 | 0.060 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2009 | 1061 | 0.060 |
Why?
| Middle Aged | 2 | 2021 | 13094 | 0.060 |
Why?
| Ovary | 1 | 2023 | 104 | 0.060 |
Why?
| Aged | 2 | 2021 | 10059 | 0.060 |
Why?
| Reproduction | 1 | 2023 | 56 | 0.060 |
Why?
| Hematopoiesis | 1 | 2022 | 80 | 0.050 |
Why?
| Cytoskeleton | 1 | 2022 | 50 | 0.050 |
Why?
| Gene Expression Regulation, Enzymologic | 2 | 2015 | 209 | 0.050 |
Why?
| Ferrets | 1 | 2021 | 6 | 0.050 |
Why?
| Mice, Transgenic | 2 | 2014 | 662 | 0.050 |
Why?
| Glycolysis | 1 | 2021 | 70 | 0.050 |
Why?
| Rats, Sprague-Dawley | 2 | 2016 | 1676 | 0.050 |
Why?
| ROC Curve | 1 | 2021 | 260 | 0.050 |
Why?
| Young Adult | 1 | 2011 | 4320 | 0.050 |
Why?
| Cell Count | 1 | 2020 | 181 | 0.050 |
Why?
| Mutagenesis, Site-Directed | 2 | 2011 | 117 | 0.050 |
Why?
| Genotype | 1 | 2021 | 607 | 0.040 |
Why?
| Heart Rate | 1 | 2021 | 353 | 0.040 |
Why?
| HCT116 Cells | 2 | 2009 | 27 | 0.040 |
Why?
| Free Radical Scavengers | 2 | 2010 | 35 | 0.040 |
Why?
| Tumor Microenvironment | 1 | 2020 | 207 | 0.040 |
Why?
| Protein Binding | 2 | 2013 | 743 | 0.040 |
Why?
| Proteomics | 1 | 2021 | 341 | 0.040 |
Why?
| Sulfhydryl Compounds | 2 | 2008 | 19 | 0.040 |
Why?
| Mice, Nude | 2 | 2009 | 284 | 0.040 |
Why?
| Bone Density | 1 | 2020 | 417 | 0.040 |
Why?
| Osteoblasts | 1 | 2021 | 526 | 0.040 |
Why?
| Hematopoietic Stem Cell Transplantation | 1 | 2022 | 570 | 0.040 |
Why?
| Flow Cytometry | 2 | 2013 | 548 | 0.040 |
Why?
| Antimycin A | 2 | 2009 | 7 | 0.040 |
Why?
| Drug Synergism | 2 | 2009 | 171 | 0.040 |
Why?
| Electron Transport | 2 | 2009 | 41 | 0.040 |
Why?
| Tumor Cells, Cultured | 2 | 2007 | 483 | 0.040 |
Why?
| Inflammation | 1 | 2021 | 677 | 0.040 |
Why?
| Peroxidase | 1 | 2016 | 20 | 0.040 |
Why?
| Glutathione Reductase | 2 | 2007 | 15 | 0.040 |
Why?
| Embryo, Mammalian | 1 | 2016 | 69 | 0.040 |
Why?
| NADP | 2 | 2007 | 27 | 0.040 |
Why?
| Neutrophil Infiltration | 1 | 2016 | 29 | 0.040 |
Why?
| Primary Cell Culture | 1 | 2016 | 65 | 0.040 |
Why?
| Bone and Bones | 1 | 2020 | 523 | 0.040 |
Why?
| Gamma Rays | 1 | 2016 | 58 | 0.040 |
Why?
| Colony-Forming Units Assay | 1 | 2015 | 31 | 0.040 |
Why?
| Rejuvenation | 1 | 2015 | 8 | 0.040 |
Why?
| Aldehydes | 1 | 2016 | 97 | 0.030 |
Why?
| Ganciclovir | 1 | 2015 | 35 | 0.030 |
Why?
| Nitric Oxide Synthase Type I | 1 | 2015 | 22 | 0.030 |
Why?
| DNA, Satellite | 1 | 2015 | 15 | 0.030 |
Why?
| NAD | 1 | 2015 | 46 | 0.030 |
Why?
| Reactive Nitrogen Species | 1 | 2015 | 39 | 0.030 |
Why?
| Microscopy | 1 | 2015 | 66 | 0.030 |
Why?
| Transforming Growth Factor beta | 1 | 2016 | 171 | 0.030 |
Why?
| DNA Transposable Elements | 1 | 2015 | 82 | 0.030 |
Why?
| bcl-X Protein | 1 | 2015 | 59 | 0.030 |
Why?
| Combined Modality Therapy | 2 | 2007 | 694 | 0.030 |
Why?
| Epigenomics | 1 | 2015 | 67 | 0.030 |
Why?
| Mitochondria, Liver | 1 | 2015 | 86 | 0.030 |
Why?
| X-Rays | 1 | 2015 | 57 | 0.030 |
Why?
| Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2014 | 6 | 0.030 |
Why?
| Collagen | 1 | 2016 | 229 | 0.030 |
Why?
| B-Lymphocytes | 1 | 2015 | 176 | 0.030 |
Why?
| Intestinal Mucosa | 1 | 2016 | 274 | 0.030 |
Why?
| Oxygen Consumption | 1 | 2015 | 234 | 0.030 |
Why?
| Cell Cycle | 1 | 2015 | 274 | 0.030 |
Why?
| Mitochondrial Membrane Transport Proteins | 1 | 2014 | 24 | 0.030 |
Why?
| NG-Nitroarginine Methyl Ester | 1 | 2014 | 21 | 0.030 |
Why?
| Electron Transport Chain Complex Proteins | 1 | 2014 | 14 | 0.030 |
Why?
| Ubiquinone | 1 | 2014 | 15 | 0.030 |
Why?
| Organophosphorus Compounds | 1 | 2014 | 17 | 0.030 |
Why?
| Cesium Radioisotopes | 1 | 2013 | 5 | 0.030 |
Why?
| Thymocytes | 1 | 2013 | 3 | 0.030 |
Why?
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2013 | 5 | 0.030 |
Why?
| Silicon | 1 | 2013 | 8 | 0.030 |
Why?
| Gene Order | 1 | 2013 | 18 | 0.030 |
Why?
| Mice, Mutant Strains | 1 | 2013 | 85 | 0.030 |
Why?
| Protein Conformation | 1 | 2014 | 227 | 0.030 |
Why?
| Neoplastic Syndromes, Hereditary | 1 | 2013 | 18 | 0.030 |
Why?
| Leukocyte Count | 1 | 2013 | 77 | 0.030 |
Why?
| Gene Targeting | 1 | 2013 | 32 | 0.030 |
Why?
| Gene Dosage | 1 | 2013 | 91 | 0.030 |
Why?
| Metabolomics | 1 | 2014 | 149 | 0.030 |
Why?
| Lipid Metabolism | 1 | 2014 | 195 | 0.030 |
Why?
| Recombinant Fusion Proteins | 1 | 2013 | 206 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 210 | 0.030 |
Why?
| Radiation Dosage | 1 | 2013 | 173 | 0.030 |
Why?
| DNA, Mitochondrial | 1 | 2014 | 189 | 0.030 |
Why?
| Up-Regulation | 1 | 2014 | 514 | 0.030 |
Why?
| Mutation Rate | 1 | 2011 | 40 | 0.030 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 473 | 0.030 |
Why?
| Point Mutation | 1 | 2011 | 93 | 0.030 |
Why?
| Plasmids | 1 | 2011 | 180 | 0.020 |
Why?
| Transglutaminases | 1 | 2010 | 17 | 0.020 |
Why?
| Tubulin | 1 | 2010 | 28 | 0.020 |
Why?
| Neuroblastoma | 1 | 2010 | 50 | 0.020 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 867 | 0.020 |
Why?
| GTP-Binding Proteins | 1 | 2010 | 95 | 0.020 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 2009 | 126 | 0.020 |
Why?
| Uncoupling Agents | 1 | 2009 | 7 | 0.020 |
Why?
| HT29 Cells | 1 | 2009 | 12 | 0.020 |
Why?
| Glycoproteins | 1 | 2010 | 132 | 0.020 |
Why?
| Muscle, Skeletal | 1 | 2015 | 843 | 0.020 |
Why?
| Polymerase Chain Reaction | 1 | 2011 | 533 | 0.020 |
Why?
| Tumor Burden | 1 | 2009 | 142 | 0.020 |
Why?
| Antigens, CD | 1 | 2010 | 242 | 0.020 |
Why?
| Stem Cells | 1 | 2010 | 192 | 0.020 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2009 | 219 | 0.020 |
Why?
| COS Cells | 1 | 2008 | 80 | 0.020 |
Why?
| Methionine Sulfoxide Reductases | 1 | 2008 | 2 | 0.020 |
Why?
| Chromatin Immunoprecipitation | 1 | 2008 | 56 | 0.020 |
Why?
| Calmodulin | 1 | 2008 | 11 | 0.020 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2008 | 100 | 0.020 |
Why?
| Cell Culture Techniques | 1 | 2008 | 112 | 0.020 |
Why?
| Oxidoreductases | 1 | 2008 | 64 | 0.020 |
Why?
| Tumor Stem Cell Assay | 1 | 2007 | 21 | 0.020 |
Why?
| Transplantation, Heterologous | 1 | 2007 | 76 | 0.020 |
Why?
| Mice, Inbred Strains | 1 | 2007 | 198 | 0.020 |
Why?
| Drug Therapy, Combination | 1 | 2008 | 428 | 0.020 |
Why?
| Down-Regulation | 1 | 2008 | 392 | 0.020 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 682 | 0.020 |
Why?
| Angiotensin II | 1 | 2008 | 166 | 0.020 |
Why?
| Nuclear Proteins | 1 | 2008 | 252 | 0.020 |
Why?
| Neurons | 1 | 2010 | 483 | 0.020 |
Why?
| Antimetabolites, Antineoplastic | 1 | 2006 | 39 | 0.020 |
Why?
| Neoplasm Proteins | 1 | 2008 | 367 | 0.020 |
Why?
| Calcium | 1 | 2008 | 434 | 0.020 |
Why?
| Methacrylates | 1 | 2004 | 8 | 0.020 |
Why?
| Electron Spin Resonance Spectroscopy | 1 | 2004 | 12 | 0.020 |
Why?
| Free Radicals | 1 | 2004 | 31 | 0.020 |
Why?
| Lung | 1 | 2008 | 512 | 0.020 |
Why?
| Electrons | 1 | 2004 | 20 | 0.020 |
Why?
| Manganese | 1 | 2004 | 24 | 0.020 |
Why?
| Cell Line, Transformed | 1 | 2004 | 88 | 0.020 |
Why?
| Oxidants | 1 | 2004 | 66 | 0.020 |
Why?
| Thiazoles | 1 | 2004 | 62 | 0.020 |
Why?
| Osteosarcoma | 1 | 2004 | 40 | 0.020 |
Why?
|
|
Aykin-Burns's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|